Miller-Rich Nancy 4
4 · Aldeyra Therapeutics, Inc. · Filed Oct 21, 2024
Insider Transaction Report
Form 4
Miller-Rich Nancy
Director
Transactions
- Purchase
Common Stock
2023-04-12$10.13/sh+509$5,156→ 922 total - Purchase
Common Stock
2021-05-03$12.81/sh+413$5,291→ 413 total
Footnotes (1)
- [F1]The purchases reported herein were executed under the trading discretion of an investment advisor in a managed account, without any instruction from or knowledge of the Reporting Person. The Reporting Person only recently become aware of these transactions.